NABRIVA THERAPEUTICS AG (an Austrian stock corporation (Aktiengesellschaft)) [●] American Depositary Shares Representing an Aggregate of [●] Common Shares UNDERWRITING AGREEMENTUnderwriting Agreement • August 24th, 2015 • Nabriva Therapeutics AG • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 24th, 2015 • Nabriva Therapeutics AG • Pharmaceutical preparations • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made as of the [ ] day of [ ], 2015, by and among Nabriva Therapeutics AG, a stock corporation (Aktiengesellschaft) incorporated in the Republic of Austria (the “Company”), each of the new investors listed on Schedule A hereto (the “New Investor”), each of the initial investors listed on Schedule B hereto (the “Initial Investor”), Sandoz GmbH, a limited liability company incorporated in the Republic of Austria (“Sandoz”, and together with the Initial Investors and the New Investors, the “Investors”) and any additional investor that becomes a party to this Agreement in accordance with Section 3.9 hereof.
BOARD MEMBER EMPLOYMENT AGREEMENT between Nabriva Therapeutics AG Leberstraße 20Board Member Employment Agreement • August 24th, 2015 • Nabriva Therapeutics AG • Pharmaceutical preparations
SUBLEASE AGREEMENTSublease Agreement • August 24th, 2015 • Nabriva Therapeutics AG • Pharmaceutical preparations • Pennsylvania
THIS SUBLEASE AGREEMENT (“Sublease”) is entered into as of the 7th day of July, 2015 by and between CARDCONNECT, LLC, a Delaware limited liability company (“CardConnect”), formerly known as FINANCIAL TRANSACTION SERVICES, LLC, having an address of 1000 Continental Drive, 3rd Floor, King of Prussia, PA 19406, as sublandlord, and NABRIVA THERAPEUTICS US, INC., a Delaware corporation, having an address of 1000 Continental Drive, Suite 450, King of Prussia, PA 19406 (“Subtenant” or “Sublessee”).
